• Skip to Management
  • Skip to Main menu
  • Skip to Page content
Adlershof Logo
  • WISTA
  • WISTA.Plan
  • WISTA.Service
WISTA direkt
Search
  • de
  • en
  • Adlershof Logo
  • About / Directory
    • Companies / Institutes
    • Science City in numbers
    • Direction / Maps
      • Bus / Train
      • By Car
      • Bicycle
      • Orientation / Maps
      • Trail of Thoughts
  • Newsroom
    • Overview
    • News
      • Social Media Stream
      • Success Stories
    • Events / Calendar
      • Adlershof Dissertation Award
      • Adlershof Research Forum
      • Long Night of Sciences Berlin
    • Adlershof Journal
    • Hot Topics
      • Adlershof Mission "Grand Challenges"
      • Circular Economy
      • Digital infra­structure / 5G campus network
    • Photos / Flyer / Downloads
      • Magazine archive
    • WISTA-Editorial Staff
  • Science / Technology
    • Overview
    • Technology Centres
      • Photonics / Optics
      • Biotech­nology / Envi­ron­ment
      • Micro­systems / Materi­als
      • IT / Media
      • Renewable Energy / Photovoltaics
    • Non-university Research
    • Universities / Colleges
      • Humboldt-Universität zu Berlin
      • Services for Students
    • Young Talents / STEM / School Labs
    • Start-Ups
      • Adlershof Start-Up Centre IGZ
      • Adlershof Founder’s Lab
    • Networks / Management
      • Campus Club Adlershof
  • TV / Media
    • TV and Movie Production
    • Media Services / Companies
    • News and Events
    • Filming Locations
    • Costume Hire
    • GDR Film Archive
    • Tickets / Booking
  • Properties
    • Overview
    • Real Estate Rent
      • Office Space / Workspace / Laboratories
    • Real Estate Offers
      • Commercial Properties
    • ST3AM Working Environments / Coworking
    • Residential
    • Construction
      • Building Projects
      • Architecture
      • Webcam
  • Service
    • Overview
    • Gastronomy / Sport / Culture / Shopping
    • Jobs / Market
    • Social and Healthcare Facilities
    • WISTA-Business Services
    • Event Services / Guided Tours / Hotels
    • Facility Management
    • Downloads / Photos / Videos
    • Jobs for Refugees
  • Hood
    • Overview
    • History
    • Nature Park
    • Culture
    • Technology Park
    • Digital Tours
  • WISTA
  • WISTA.Plan
  • WISTA.Service
WISTA direkt

News

  • Overview
  • News
  • Events / Calendar
  • Adlershof Journal
  • Hot Topics
  • Photos / Flyer / Downloads
  • WISTA-Editorial Staff
  • Adlershof
  • Newsroom
  • News
07. May 2013

MagForce AG Receives Further Patent Related to NanoTherm® Therapy

European patent granted for nanoparticle-drug conjugates

MagForce AG, a leading medical technology company in the field of nanomedicine in oncology, announced today that the Company has been granted a further European patent for its NanoTherm® therapy, for which the opposition period has now expired. Patent EP 1871423 B1 relates to a new generation of NanoTherm® particles in the form of nanoparticle-drug conjugates, which are suitable for drug delivery systems.

Nanoparticle-drug conjugates inside a tumor can be heated selectively by an alternating magnetic field leading to a temperature-dependent release of the drug inside the tumor tissue producing a high local drug concentration. Additionally the known synergistic effects of chemotherapy in combination with hyperthermia can be utilized.

"The locally limited and externally controllable drug release by means of the now patent-protected conjugates is expected to clearly reduce the mostly considerable side-effects of conventional chemotherapeutic agents. Combining thermotherapy with nanoparticle-bound chemotherapy could also substantially increase the effectiveness of the chemotherapeutic agent in tumor treatment and reduce the number of nanoparticles required to destroy the cancer cells," commented Prof. Dr. Hoda Tawfik, COO and co-CEO of MagForce.

About NanoTherm® Therapy
The NanoTherm® Therapy is a new approach for the local treatment of solid tumors. The principle of the method is the direct introduction of superparamagnetic nanoparticles into a tumor and their subsequent heating in an alternating magnetic field. The nanoparticles are extremely small (approximately 15 nanometers in diameter) and contain an iron oxide core with an aminosilane coating. The particles are activated by a magnetic field that changes its polarity 100,000 times per second, and heat is produced. Depending on the duration of treatment and the achieved intratumoral temperatures, the tumor cells are either directly destroyed (thermal ablation) or sensitized for concomitant chemotherapy or radiotherapy (hyperthermia). With this new therapeutic approach, it is possible to combat the tumor from the inside out, thereby sparing surrounding healthy tissue. The nanoparticles remain in place at the treatment area, allowing for repeat treatments and the integration of multimodal therapy concepts. NanoTherm® Therapy has regulatory approval in 27 European countries.

About MagForce AG
MagForce AG is a leading medical technology company in the field of nanomedicine in oncology. The Company's proprietary, NanoTherm® therapy, enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm®, NanoPlan®, and NanoActivator(TM) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm®, NanoPlan®, and NanoActivator(TM) are trademarks of MagForce AG in selected countries. For more information, please visit www.magforce.com.

Source:

MagForce_Press Release_May 07, 2013

  • LinkedInshare0
  • Facebookshare0
  • WhatsAppshare0
  • E-Mail

The development of the Science and Technology Park Berlin Adlershof was and is co-financed by the European Union namely by EFRE. This concerns infrastructure development like construction of technology centres. Furthermore EFRE is used for international projects.

  • © WISTA Management GmbH
  • Legal Notice
  • Privacy Policy
  • Social Media Guide
  • FAQ
  • Contact
  • Press
  • Newsletter
  • RSS
  • International
Member of:
Zukunftsort Adlershof Logo